A Study to Assess the Efficacy and Safety of the Combination of Simeprevir and Daclatasvir in Chronic Hepatitis C Genotype 1b-Infected Participants
Clinical trial NCT02268864 · COMPLETED
Trial details
- NCT number
- NCT02268864
- Sponsor
- Janssen-Cilag International NV
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2016-01-01
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.